AtriCure endures continued income losses for Q3

AtriCure, a developer of cardiac surgical ablation systems, has reported a rise in net losses and a lowering of revenues for the 2009 third quarter compared with the previous year-ago quarter.

Net losses for the 2009 third quarter rose to $4.7 million, compared with $1.77 million in the 2008 third quarter, according to the West Chester, Ohio-based company.

Revenues for the third quarter of 2009 were $13.3 million, a 10.3 percent decrease over third quarter 2008 revenues of $14.8 million, AtriCure said. Revenues from open-heart products for the third quarter of 2009 were $6.5 million compared with $6.7 million for the third quarter of 2008. Revenues from domestic minimally invasive products declined from $5.7 million for the third quarter of 2008 to $4.2 million for the third quarter of 2009.

Operating expenses for the third quarter of 2009 were $14.4 million compared with $13.2 million for the third quarter of 2008.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."